Taft Stettinius & Hollister LLP advised StemoniX, Inc on the deal. Cancer Genetics, Inc. (the “Company” or “CGI”) (Nasdaq: CGIX), an emerging leader in novel drug...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here